000 | 01397 a2200433 4500 | ||
---|---|---|---|
005 | 20250516002626.0 | ||
264 | 0 | _c20110331 | |
008 | 201103s 0 0 eng d | ||
022 | _a1421-9867 | ||
024 | 7 |
_a10.1159/000315898 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHorjus, C S | |
245 | 0 | 0 |
_aMicroalbuminuria is not a valuable marker for relapse in Crohn's disease. _h[electronic resource] |
260 |
_bDigestion _c2011 |
||
300 |
_a41-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlbuminuria _xetiology |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
650 | 0 | 4 |
_aBiomarkers _xurine |
650 | 0 | 4 |
_aBudesonide _xadministration & dosage |
650 | 0 | 4 |
_aCrohn Disease _xdiagnosis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _avan Oijen, M G H | |
700 | 1 | _aDavids, A H | |
700 | 1 | _aNaber, A H J | |
700 | 1 | _ade Jong, D J | |
773 | 0 |
_tDigestion _gvol. 83 _gno. 1-2 _gp. 41-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000315898 _zAvailable from publisher's website |
999 |
_c20178048 _d20178048 |